PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Ozone therapy induced sinus arrest in a hypertensive patient with chronic kidney disease: A case report.

Abstract Ozone autohemotherapy as an alternative treatment method has been applied to the treatment of several diseases. Here, we report a patient used ozone autohemotherapy to treat her hypertension and diabetes. Nevertheless, the patient occurred sudden dizziness and black haze due to hyperkalemia.
PMID
Related Publications

Carvedilol-induced hyperkalemia in a patient with chronic kidney disease.

Emergency Department Use among Patients with CKD: A Population-Based Analysis.

Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.

Hyperkalemia induced failure of atrial and ventricular pacemaker capture.

Tetraparesis and failure of pacemaker capture induced by severe hyperkalemia: case report and systematic review of available literature.

Authors

Mayor MeshTerms
Keywords
Journal Title medicine
Publication Year Start




PMID- 29390373
OWN - NLM
STAT- MEDLINE
DCOM- 20180212
LR  - 20180212
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 96
IP  - 50
DP  - 2017 Dec
TI  - Ozone therapy induced sinus arrest in a hypertensive patient with chronic kidney 
      disease: A case report.
PG  - e9265
LID - 10.1097/MD.0000000000009265 [doi]
AB  - RATIONALE: Ozone autohemotherapy as an alternative treatment method has been
      applied to the treatment of several diseases. Here, we report a patient used
      ozone autohemotherapy to treat her hypertension and diabetes. Nevertheless, the
      patient occurred sudden dizziness and black haze due to hyperkalemia. PATIENT
      CONCERNS: A 54-year-old woman who was admitted to our emergency department
      complaining of sudden dizziness and black haze for 5 hours. DIAGNOSES: The blood 
      potassium test showed hyperkalemia. Upon further inquiry of her medical history, 
      the patient received ozone autohemotherapy to treat hypertension and diabetes for
      9 days prior to admission. INTERVENTIONS: The ozone therapy had been asked to
      stop. Insulin, sodium bicarbonate, and sodium polystyrene sulfonate were
      administered to the patient. OUTCOMES: After treatment, blood potassium remained 
      in the normal range. After 3 days of treatment, the 24-hour dynamic
      electrocardiogram revealed sinus rhythm with an average heart rate of 82
      beats/min, occasional ventricular premature beats, occasional ventricular
      premature beats, and no ST segment depression. LESSONS: Although ozone therapy is
      widely used in the treatment of several diseases, adverse reactions should be
      given attention in clinical practice, especially in patients with chronic kidney 
      disease.
CI  - Copyright (c) 2017 The Authors. Published by Wolters Kluwer Health, Inc. All
      rights reserved.
FAU - Tang, Wen-Juan
AU  - Tang WJ
AD  - The General Hospital of FAW, The Fourth Hospital of Jilin University, Changchun, 
      Jilin Province.
FAU - Jiang, Long
AU  - Jiang L
AD  - Department of Cardiovascular, the Second Affiliated Hospital of Nanchang
      University, Nanchang, Jiangxi Province.
FAU - Wang, Ying
AU  - Wang Y
AD  - Department of Cardiology, the Chenzhou City First People's Hospital Affiliated to
      University of South China, Chenzhou, Hunan.
FAU - Kuang, Ze-Min
AU  - Kuang ZM
AD  - Department of Hypertension, Beijing Anzhen Hospital of Capital Medical
      University, Beijing, China.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
RN  - 66H7ZZK23N (Ozone)
SB  - AIM
SB  - IM
MH  - Electrocardiography
MH  - Female
MH  - Humans
MH  - Hyperkalemia/*etiology/therapy
MH  - Hypertension/complications/*therapy
MH  - Middle Aged
MH  - Ozone/*adverse effects
MH  - Renal Insufficiency, Chronic/*complications
MH  - Sick Sinus Syndrome/*etiology/therapy
EDAT- 2018/02/03 06:00
MHDA- 2018/02/13 06:00
CRDT- 2018/02/03 06:00
PHST- 2018/02/03 06:00 [entrez]
PHST- 2018/02/03 06:00 [pubmed]
PHST- 2018/02/13 06:00 [medline]
AID - 10.1097/MD.0000000000009265 [doi]
AID - 00005792-201712150-00123 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2017 Dec;96(50):e9265. doi: 10.1097/MD.0000000000009265.